Breaking News

Onyx Scientific Appoints BD Director

November 19, 2012

Brisard will oversee business across the eastern half of the U.S.

Onyx Scientific has appointed Dan Brisard as business development director. Based in Chicago, Mr. Brisard will oversee the contract manufacturing business development activities across the eastern half of the U.S. He is an experienced commercial executive and has worked across the pharmaceutical manufacturing sector for 15 years, including seven years with Ricerca Bioscience.
 
Denise Bowser, commercial director at Onyx Scientific, said, “Having Dan on board is a massive boost to the company as he brings exceptional commercial experience gained in the industry along with a strong chemistry background. Dan will play a key role in communicating the breadth of our services in addition to our track record and achievements to the US market.”
blog comments powered by Disqus
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • Setting a Precedent for Biosimilars in the U.S.

    Setting a Precedent for Biosimilars in the U.S.

    Kristin Brooks, Contract Pharma||May 19, 2015
    Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain

  • API Sourcing Trends

    API Sourcing Trends

    Kristin Brooks, Contract Pharma||March 19, 2015
    Ed Price of PCI Synthesis addresses trends, regulatory and supply chain hurdles, and quality concerns

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent

  • Biopharma CMO Market Trends

    Biopharma CMO Market Trends

    Tim Wright, Editor||June 2, 2016
    Continued strong growth in biopharma industry is being driven by biosimilars

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.